NASDAQ:SGRY Surgery Partners (SGRY) Stock Price, News & Analysis $30.18 -0.81 (-2.61%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$29.60▼$31.0350-Day Range$23.08▼$33.6952-Week Range$22.05▼$36.92Volume714,993 shsAverage Volume977,020 shsMarket Capitalization$3.84 billionP/E Ratio43.58Dividend YieldN/APrice Target$39.86 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Surgery Partners alerts: Email Address Surgery Partners MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.86 Rating ScoreUpside/Downside32.1% Upside$39.86 Price TargetShort InterestBearish15.96% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.96Based on 4 Articles This WeekInsider TradingSelling Shares$158,340 Sold Last QuarterProj. Earnings Growth29.89%From $0.87 to $1.13 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.40 out of 5 starsMedical Sector260th out of 910 stocksGeneral Medical & Surgical Hospitals Industry5th out of 5 stocks 4.4 Analyst's Opinion Consensus RatingSurgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageSurgery Partners has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Surgery Partners' stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted15.96% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 10.1, which indicates bearish sentiment.Change versus previous monthShort interest in Surgery Partners has recently increased by 3.38%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSurgery Partners does not currently pay a dividend.Dividend GrowthSurgery Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SGRY. Previous Next 2.2 News and Social Media Coverage News SentimentSurgery Partners has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Surgery Partners this week, compared to 4 articles on an average week.Search InterestOnly 2 people have searched for SGRY on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $158,340.00 in company stock.Percentage Held by InsidersOnly 2.30% of the stock of Surgery Partners is held by insiders.Read more about Surgery Partners' insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Surgery Partners are expected to grow by 29.89% in the coming year, from $0.87 to $1.13 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surgery Partners is 43.58, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.87.Price to Earnings Ratio vs. SectorThe P/E ratio of Surgery Partners is 43.58, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 115.64.Price to Earnings Growth RatioSurgery Partners has a PEG Ratio of 2.33. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSurgery Partners has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Surgery Partners' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. About Surgery Partners Stock (NASDAQ:SGRY)Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.Read More SGRY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SGRY Stock News HeadlinesSeptember 4 at 11:15 AM | finance.yahoo.comSlowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For ExcitementAugust 29, 2024 | bizjournals.comPublic health care company Surgery Partners eyes potential saleSeptember 7, 2024 | Weiss Ratings (Ad)Who are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.August 28, 2024 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Sees Large Volume IncreaseAugust 28, 2024 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Rating Reiterated by BenchmarkAugust 26, 2024 | markets.businessinsider.comBenchmark Co. Sticks to Their Buy Rating for Surgery Partners (SGRY)August 23, 2024 | msn.comSurgery Partners jumps after report of interest from UnitedHealth, TPGAugust 21, 2024 | msn.comConcentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says AnalystSeptember 7, 2024 | Weiss Ratings (Ad)Who are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.August 19, 2024 | benzinga.comWhat 8 Analyst Ratings Have To Say About Surgery PartnersAugust 12, 2024 | markets.businessinsider.comSurgery Partners’ Strong Q2 Performance and Upward 2024 Guidance Fuel Buy RatingAugust 9, 2024 | markets.businessinsider.comSurgery Partners: Strong Q2 Performance and Growth Potential Affirm Buy RatingAugust 9, 2024 | markets.businessinsider.comSurgery Partners: Balancing Solid Revenue Growth Against Free Cash Flow ConcernsAugust 8, 2024 | markets.businessinsider.comSurgery Partners: Strong Financials and Expansion Efforts Support Buy RatingAugust 7, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Amgen (AMGN), Caribou Biosciences (CRBU) and Surgery Partners (SGRY)August 7, 2024 | markets.businessinsider.comRBC Capital Reaffirms Their Buy Rating on Surgery Partners (SGRY)August 7, 2024 | seekingalpha.comSurgery Partners, Inc. (SGRY) Q2 2024 Earnings Call TranscriptAugust 6, 2024 | globenewswire.comSurgery Partners, Inc. Announces Second Quarter 2024 Results Raises Full Year 2024 GuidanceSee More Headlines Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/06/2024Today9/07/2024Next Earnings (Estimated)11/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry General medical & surgical hospitals Sub-IndustryHealthcare Current SymbolNASDAQ:SGRY CUSIPN/A CIK1638833 Webwww.surgerypartners.com Phone(615) 234-5900Fax615-234-5998Employees13,500Year FoundedN/APrice Target and Rating Average Stock Price Target$39.86 High Stock Price Target$50.00 Low Stock Price Target$31.00 Potential Upside/Downside+32.1%Consensus RatingModerate Buy Rating Score (0-4)2.86 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio45.00 Forward P/E Ratio34.69 P/E GrowthN/ANet Income$-11,900,000.00 Net Margins-1.17% Pretax Margin5.11% Return on Equity2.96% Return on Assets1.29% Debt Debt-to-Equity Ratio0.96 Current Ratio1.83 Quick Ratio1.69 Sales & Book Value Annual Sales$2.74 billion Price / Sales1.40 Cash Flow$1.70 per share Price / Cash Flow17.80 Book Value$23.99 per share Price / Book1.26Miscellaneous Outstanding Shares127,120,000Free Float124,171,000Market Cap$3.84 billion OptionableOptionable Beta2.76 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Wayne Scott DeVeydt (Age 54)Executive Chairman Comp: $250kMr. J. Eric Evans (Age 47)CEO & Director Comp: $2.06MMr. David T. Doherty (Age 52)Executive VP & CFO Comp: $1.12MMs. Jennifer B. Baldock (Age 53)Executive VP and Chief Administrative & Development Officer Comp: $1.11MMr. Bradley R. Owens (Age 54)President of National Group Comp: $807.6kMs. Marissa A. Brittenham (Age 39)Executive VP & Chief Strategy Officer Comp: $677.29kMr. Neil C. Zieselman (Age 48)Senior Vice President of Corporate Finance & Controller Mr. Varun GadhokSenior VP & Chief Information OfficerMs. Roxanne WomackSenior VP & Chief Compliance OfficerMs. Danielle Burkhalter (Age 39)Executive VP & Chief Human Resources Officer More ExecutivesKey CompetitorsCommunity Health SystemsNYSE:CYHNateraNASDAQ:NTRAFresenius Medical CareNYSE:FMSPACS GroupNYSE:PACSOption Care HealthNASDAQ:OPCHView All CompetitorsInsiders & InstitutionsClearbridge Investments LLCBought 73,007 shares on 8/27/2024Ownership: 4.395%MidWestOne Financial Group Inc.Bought 10,340 shares on 8/16/2024Ownership: 0.056%Susquehanna International Group LLPSold 57,800 shares on 8/16/2024Ownership: 0.000%Quarry LPBought 1,760 shares on 8/16/2024Ownership: 0.002%Mackenzie Financial CorpBought 662 shares on 8/15/2024Ownership: 0.016%View All Insider TransactionsView All Institutional Transactions SGRY Stock Analysis - Frequently Asked Questions How have SGRY shares performed this year? Surgery Partners' stock was trading at $31.99 at the start of the year. Since then, SGRY stock has decreased by 5.7% and is now trading at $30.18. View the best growth stocks for 2024 here. How were Surgery Partners' earnings last quarter? Surgery Partners, Inc. (NASDAQ:SGRY) posted its quarterly earnings results on Tuesday, August, 6th. The company reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.01. The firm's quarterly revenue was up 14.2% compared to the same quarter last year. What is Eric Evans' approval rating as Surgery Partners' CEO? 7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees. Who are Surgery Partners' major shareholders? Surgery Partners' top institutional shareholders include Clearbridge Investments LLC (4.39%), Deerfield Management Company L.P. Series C (3.70%), Dimensional Fund Advisors LP (2.20%) and Point72 Asset Management L.P. (0.97%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, Jennifer Baldock, Wayne S Deveydt, David T Doherty, Bradley R Owens, Brent Turner, Harrison R Bane, Laura L Brocklehurst, George Goodwin, Marissa Brittenham, Danielle Burkhalter, Teresa Deluca and Anthony Taparo. View institutional ownership trends. How do I buy shares of Surgery Partners? Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Surgery Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO) and Xilinx (XLNX). This page (NASDAQ:SGRY) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.